Global Cannabinoid-based Products for Cancer Market Research Report 2023
This report aims to provide a comprehensive presentation of the global market for Cannabinoid-based Products for Cancer, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cannabinoid-based Products for Cancer.
The Cannabinoid-based Products for Cancer market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Cannabinoid-based Products for Cancer market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cannabinoid-based Products for Cancer companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cannabinoid-based Products for Cancer companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The Cannabinoid-based Products for Cancer market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Cannabinoid-based Products for Cancer market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cannabinoid-based Products for Cancer companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
- Bausch Health
- GW Pharmaceuticals
- Cannabics Inc.
- Tikun Olam
- Jay Pharma
- Smoking Products
- Food Products
- Oil
- Coat Product
- Other
- Clinics
- Hospitals
- Others
- North America
- United States
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Nordic Countries
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cannabinoid-based Products for Cancer companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 REPORT OVERVIEW
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cannabinoid-based Products for Cancer Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Smoking Products
1.2.3 Food Products
1.2.4 Oil
1.2.5 Coat Product
1.2.6 Other
1.3 Market by Application
1.3.1 Global Cannabinoid-based Products for Cancer Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Clinics
1.3.3 Hospitals
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global Cannabinoid-based Products for Cancer Market Perspective (2018-2029)
2.2 Cannabinoid-based Products for Cancer Growth Trends by Region
2.2.1 Global Cannabinoid-based Products for Cancer Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Cannabinoid-based Products for Cancer Historic Market Size by Region (2018-2023)
2.2.3 Cannabinoid-based Products for Cancer Forecasted Market Size by Region (2024-2029)
2.3 Cannabinoid-based Products for Cancer Market Dynamics
2.3.1 Cannabinoid-based Products for Cancer Industry Trends
2.3.2 Cannabinoid-based Products for Cancer Market Drivers
2.3.3 Cannabinoid-based Products for Cancer Market Challenges
2.3.4 Cannabinoid-based Products for Cancer Market Restraints
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Cannabinoid-based Products for Cancer Players by Revenue
3.1.1 Global Top Cannabinoid-based Products for Cancer Players by Revenue (2018-2023)
3.1.2 Global Cannabinoid-based Products for Cancer Revenue Market Share by Players (2018-2023)
3.2 Global Cannabinoid-based Products for Cancer Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cannabinoid-based Products for Cancer Revenue
3.4 Global Cannabinoid-based Products for Cancer Market Concentration Ratio
3.4.1 Global Cannabinoid-based Products for Cancer Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cannabinoid-based Products for Cancer Revenue in 2022
3.5 Cannabinoid-based Products for Cancer Key Players Head office and Area Served
3.6 Key Players Cannabinoid-based Products for Cancer Product Solution and Service
3.7 Date of Enter into Cannabinoid-based Products for Cancer Market
3.8 Mergers & Acquisitions, Expansion Plans
4 CANNABINOID-BASED PRODUCTS FOR CANCER BREAKDOWN DATA BY TYPE
4.1 Global Cannabinoid-based Products for Cancer Historic Market Size by Type (2018-2023)
4.2 Global Cannabinoid-based Products for Cancer Forecasted Market Size by Type (2024-2029)
5 CANNABINOID-BASED PRODUCTS FOR CANCER BREAKDOWN DATA BY APPLICATION
5.1 Global Cannabinoid-based Products for Cancer Historic Market Size by Application (2018-2023)
5.2 Global Cannabinoid-based Products for Cancer Forecasted Market Size by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Cannabinoid-based Products for Cancer Market Size (2018-2029)
6.2 North America Cannabinoid-based Products for Cancer Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Cannabinoid-based Products for Cancer Market Size by Country (2018-2023)
6.4 North America Cannabinoid-based Products for Cancer Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 EUROPE
7.1 Europe Cannabinoid-based Products for Cancer Market Size (2018-2029)
7.2 Europe Cannabinoid-based Products for Cancer Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Cannabinoid-based Products for Cancer Market Size by Country (2018-2023)
7.4 Europe Cannabinoid-based Products for Cancer Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 ASIA-PACIFIC
8.1 Asia-Pacific Cannabinoid-based Products for Cancer Market Size (2018-2029)
8.2 Asia-Pacific Cannabinoid-based Products for Cancer Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Cannabinoid-based Products for Cancer Market Size by Region (2018-2023)
8.4 Asia-Pacific Cannabinoid-based Products for Cancer Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 LATIN AMERICA
9.1 Latin America Cannabinoid-based Products for Cancer Market Size (2018-2029)
9.2 Latin America Cannabinoid-based Products for Cancer Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Cannabinoid-based Products for Cancer Market Size by Country (2018-2023)
9.4 Latin America Cannabinoid-based Products for Cancer Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Cannabinoid-based Products for Cancer Market Size (2018-2029)
10.2 Middle East & Africa Cannabinoid-based Products for Cancer Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Cannabinoid-based Products for Cancer Market Size by Country (2018-2023)
10.4 Middle East & Africa Cannabinoid-based Products for Cancer Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 KEY PLAYERS PROFILES
11.1 Bausch Health
11.1.1 Bausch Health Company Detail
11.1.2 Bausch Health Business Overview
11.1.3 Bausch Health Cannabinoid-based Products for Cancer Introduction
11.1.4 Bausch Health Revenue in Cannabinoid-based Products for Cancer Business (2018-2023)
11.1.5 Bausch Health Recent Development
11.2 GW Pharmaceuticals
11.2.1 GW Pharmaceuticals Company Detail
11.2.2 GW Pharmaceuticals Business Overview
11.2.3 GW Pharmaceuticals Cannabinoid-based Products for Cancer Introduction
11.2.4 GW Pharmaceuticals Revenue in Cannabinoid-based Products for Cancer Business (2018-2023)
11.2.5 GW Pharmaceuticals Recent Development
11.3 Cannabics Inc.
11.3.1 Cannabics Inc. Company Detail
11.3.2 Cannabics Inc. Business Overview
11.3.3 Cannabics Inc. Cannabinoid-based Products for Cancer Introduction
11.3.4 Cannabics Inc. Revenue in Cannabinoid-based Products for Cancer Business (2018-2023)
11.3.5 Cannabics Inc. Recent Development
11.4 Tikun Olam
11.4.1 Tikun Olam Company Detail
11.4.2 Tikun Olam Business Overview
11.4.3 Tikun Olam Cannabinoid-based Products for Cancer Introduction
11.4.4 Tikun Olam Revenue in Cannabinoid-based Products for Cancer Business (2018-2023)
11.4.5 Tikun Olam Recent Development
11.5 Jay Pharma
11.5.1 Jay Pharma Company Detail
11.5.2 Jay Pharma Business Overview
11.5.3 Jay Pharma Cannabinoid-based Products for Cancer Introduction
11.5.4 Jay Pharma Revenue in Cannabinoid-based Products for Cancer Business (2018-2023)
11.5.5 Jay Pharma Recent Development
12 ANALYST'S VIEWPOINTS/CONCLUSIONS
13 APPENDIX
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cannabinoid-based Products for Cancer Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Smoking Products
1.2.3 Food Products
1.2.4 Oil
1.2.5 Coat Product
1.2.6 Other
1.3 Market by Application
1.3.1 Global Cannabinoid-based Products for Cancer Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Clinics
1.3.3 Hospitals
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global Cannabinoid-based Products for Cancer Market Perspective (2018-2029)
2.2 Cannabinoid-based Products for Cancer Growth Trends by Region
2.2.1 Global Cannabinoid-based Products for Cancer Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Cannabinoid-based Products for Cancer Historic Market Size by Region (2018-2023)
2.2.3 Cannabinoid-based Products for Cancer Forecasted Market Size by Region (2024-2029)
2.3 Cannabinoid-based Products for Cancer Market Dynamics
2.3.1 Cannabinoid-based Products for Cancer Industry Trends
2.3.2 Cannabinoid-based Products for Cancer Market Drivers
2.3.3 Cannabinoid-based Products for Cancer Market Challenges
2.3.4 Cannabinoid-based Products for Cancer Market Restraints
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Cannabinoid-based Products for Cancer Players by Revenue
3.1.1 Global Top Cannabinoid-based Products for Cancer Players by Revenue (2018-2023)
3.1.2 Global Cannabinoid-based Products for Cancer Revenue Market Share by Players (2018-2023)
3.2 Global Cannabinoid-based Products for Cancer Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cannabinoid-based Products for Cancer Revenue
3.4 Global Cannabinoid-based Products for Cancer Market Concentration Ratio
3.4.1 Global Cannabinoid-based Products for Cancer Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cannabinoid-based Products for Cancer Revenue in 2022
3.5 Cannabinoid-based Products for Cancer Key Players Head office and Area Served
3.6 Key Players Cannabinoid-based Products for Cancer Product Solution and Service
3.7 Date of Enter into Cannabinoid-based Products for Cancer Market
3.8 Mergers & Acquisitions, Expansion Plans
4 CANNABINOID-BASED PRODUCTS FOR CANCER BREAKDOWN DATA BY TYPE
4.1 Global Cannabinoid-based Products for Cancer Historic Market Size by Type (2018-2023)
4.2 Global Cannabinoid-based Products for Cancer Forecasted Market Size by Type (2024-2029)
5 CANNABINOID-BASED PRODUCTS FOR CANCER BREAKDOWN DATA BY APPLICATION
5.1 Global Cannabinoid-based Products for Cancer Historic Market Size by Application (2018-2023)
5.2 Global Cannabinoid-based Products for Cancer Forecasted Market Size by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Cannabinoid-based Products for Cancer Market Size (2018-2029)
6.2 North America Cannabinoid-based Products for Cancer Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Cannabinoid-based Products for Cancer Market Size by Country (2018-2023)
6.4 North America Cannabinoid-based Products for Cancer Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 EUROPE
7.1 Europe Cannabinoid-based Products for Cancer Market Size (2018-2029)
7.2 Europe Cannabinoid-based Products for Cancer Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Cannabinoid-based Products for Cancer Market Size by Country (2018-2023)
7.4 Europe Cannabinoid-based Products for Cancer Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 ASIA-PACIFIC
8.1 Asia-Pacific Cannabinoid-based Products for Cancer Market Size (2018-2029)
8.2 Asia-Pacific Cannabinoid-based Products for Cancer Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Cannabinoid-based Products for Cancer Market Size by Region (2018-2023)
8.4 Asia-Pacific Cannabinoid-based Products for Cancer Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 LATIN AMERICA
9.1 Latin America Cannabinoid-based Products for Cancer Market Size (2018-2029)
9.2 Latin America Cannabinoid-based Products for Cancer Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Cannabinoid-based Products for Cancer Market Size by Country (2018-2023)
9.4 Latin America Cannabinoid-based Products for Cancer Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Cannabinoid-based Products for Cancer Market Size (2018-2029)
10.2 Middle East & Africa Cannabinoid-based Products for Cancer Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Cannabinoid-based Products for Cancer Market Size by Country (2018-2023)
10.4 Middle East & Africa Cannabinoid-based Products for Cancer Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 KEY PLAYERS PROFILES
11.1 Bausch Health
11.1.1 Bausch Health Company Detail
11.1.2 Bausch Health Business Overview
11.1.3 Bausch Health Cannabinoid-based Products for Cancer Introduction
11.1.4 Bausch Health Revenue in Cannabinoid-based Products for Cancer Business (2018-2023)
11.1.5 Bausch Health Recent Development
11.2 GW Pharmaceuticals
11.2.1 GW Pharmaceuticals Company Detail
11.2.2 GW Pharmaceuticals Business Overview
11.2.3 GW Pharmaceuticals Cannabinoid-based Products for Cancer Introduction
11.2.4 GW Pharmaceuticals Revenue in Cannabinoid-based Products for Cancer Business (2018-2023)
11.2.5 GW Pharmaceuticals Recent Development
11.3 Cannabics Inc.
11.3.1 Cannabics Inc. Company Detail
11.3.2 Cannabics Inc. Business Overview
11.3.3 Cannabics Inc. Cannabinoid-based Products for Cancer Introduction
11.3.4 Cannabics Inc. Revenue in Cannabinoid-based Products for Cancer Business (2018-2023)
11.3.5 Cannabics Inc. Recent Development
11.4 Tikun Olam
11.4.1 Tikun Olam Company Detail
11.4.2 Tikun Olam Business Overview
11.4.3 Tikun Olam Cannabinoid-based Products for Cancer Introduction
11.4.4 Tikun Olam Revenue in Cannabinoid-based Products for Cancer Business (2018-2023)
11.4.5 Tikun Olam Recent Development
11.5 Jay Pharma
11.5.1 Jay Pharma Company Detail
11.5.2 Jay Pharma Business Overview
11.5.3 Jay Pharma Cannabinoid-based Products for Cancer Introduction
11.5.4 Jay Pharma Revenue in Cannabinoid-based Products for Cancer Business (2018-2023)
11.5.5 Jay Pharma Recent Development
12 ANALYST'S VIEWPOINTS/CONCLUSIONS
13 APPENDIX
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
LIST OF TABLES
Table 1. Global Cannabinoid-based Products for Cancer Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Smoking Products
Table 3. Key Players of Food Products
Table 4. Key Players of Oil
Table 5. Key Players of Coat Product
Table 6. Key Players of Other
Table 7. Global Cannabinoid-based Products for Cancer Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 8. Global Cannabinoid-based Products for Cancer Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 9. Global Cannabinoid-based Products for Cancer Market Size by Region (2018-2023) & (US$ Million)
Table 10. Global Cannabinoid-based Products for Cancer Market Share by Region (2018-2023)
Table 11. Global Cannabinoid-based Products for Cancer Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 12. Global Cannabinoid-based Products for Cancer Market Share by Region (2024-2029)
Table 13. Cannabinoid-based Products for Cancer Market Trends
Table 14. Cannabinoid-based Products for Cancer Market Drivers
Table 15. Cannabinoid-based Products for Cancer Market Challenges
Table 16. Cannabinoid-based Products for Cancer Market Restraints
Table 17. Global Cannabinoid-based Products for Cancer Revenue by Players (2018-2023) & (US$ Million)
Table 18. Global Cannabinoid-based Products for Cancer Market Share by Players (2018-2023)
Table 19. Global Top Cannabinoid-based Products for Cancer Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cannabinoid-based Products for Cancer as of 2022)
Table 20. Ranking of Global Top Cannabinoid-based Products for Cancer Companies by Revenue (US$ Million) in 2022
Table 21. Global 5 Largest Players Market Share by Cannabinoid-based Products for Cancer Revenue (CR5 and HHI) & (2018-2023)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Cannabinoid-based Products for Cancer Product Solution and Service
Table 24. Date of Enter into Cannabinoid-based Products for Cancer Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Cannabinoid-based Products for Cancer Market Size by Type (2018-2023) & (US$ Million)
Table 27. Global Cannabinoid-based Products for Cancer Revenue Market Share by Type (2018-2023)
Table 28. Global Cannabinoid-based Products for Cancer Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 29. Global Cannabinoid-based Products for Cancer Revenue Market Share by Type (2024-2029)
Table 30. Global Cannabinoid-based Products for Cancer Market Size by Application (2018-2023) & (US$ Million)
Table 31. Global Cannabinoid-based Products for Cancer Revenue Market Share by Application (2018-2023)
Table 32. Global Cannabinoid-based Products for Cancer Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 33. Global Cannabinoid-based Products for Cancer Revenue Market Share by Application (2024-2029)
Table 34. North America Cannabinoid-based Products for Cancer Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. North America Cannabinoid-based Products for Cancer Market Size by Country (2018-2023) & (US$ Million)
Table 36. North America Cannabinoid-based Products for Cancer Market Size by Country (2024-2029) & (US$ Million)
Table 37. Europe Cannabinoid-based Products for Cancer Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 38. Europe Cannabinoid-based Products for Cancer Market Size by Country (2018-2023) & (US$ Million)
Table 39. Europe Cannabinoid-based Products for Cancer Market Size by Country (2024-2029) & (US$ Million)
Table 40. Asia-Pacific Cannabinoid-based Products for Cancer Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 41. Asia-Pacific Cannabinoid-based Products for Cancer Market Size by Region (2018-2023) & (US$ Million)
Table 42. Asia-Pacific Cannabinoid-based Products for Cancer Market Size by Region (2024-2029) & (US$ Million)
Table 43. Latin America Cannabinoid-based Products for Cancer Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Latin America Cannabinoid-based Products for Cancer Market Size by Country (2018-2023) & (US$ Million)
Table 45. Latin America Cannabinoid-based Products for Cancer Market Size by Country (2024-2029) & (US$ Million)
Table 46. Middle East & Africa Cannabinoid-based Products for Cancer Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 47. Middle East & Africa Cannabinoid-based Products for Cancer Market Size by Country (2018-2023) & (US$ Million)
Table 48. Middle East & Africa Cannabinoid-based Products for Cancer Market Size by Country (2024-2029) & (US$ Million)
Table 49. Bausch Health Company Detail
Table 50. Bausch Health Business Overview
Table 51. Bausch Health Cannabinoid-based Products for Cancer Product
Table 52. Bausch Health Revenue in Cannabinoid-based Products for Cancer Business (2018-2023) & (US$ Million)
Table 53. Bausch Health Recent Development
Table 54. GW Pharmaceuticals Company Detail
Table 55. GW Pharmaceuticals Business Overview
Table 56. GW Pharmaceuticals Cannabinoid-based Products for Cancer Product
Table 57. GW Pharmaceuticals Revenue in Cannabinoid-based Products for Cancer Business (2018-2023) & (US$ Million)
Table 58. GW Pharmaceuticals Recent Development
Table 59. Cannabics Inc. Company Detail
Table 60. Cannabics Inc. Business Overview
Table 61. Cannabics Inc. Cannabinoid-based Products for Cancer Product
Table 62. Cannabics Inc. Revenue in Cannabinoid-based Products for Cancer Business (2018-2023) & (US$ Million)
Table 63. Cannabics Inc. Recent Development
Table 64. Tikun Olam Company Detail
Table 65. Tikun Olam Business Overview
Table 66. Tikun Olam Cannabinoid-based Products for Cancer Product
Table 67. Tikun Olam Revenue in Cannabinoid-based Products for Cancer Business (2018-2023) & (US$ Million)
Table 68. Tikun Olam Recent Development
Table 69. Jay Pharma Company Detail
Table 70. Jay Pharma Business Overview
Table 71. Jay Pharma Cannabinoid-based Products for Cancer Product
Table 72. Jay Pharma Revenue in Cannabinoid-based Products for Cancer Business (2018-2023) & (US$ Million)
Table 73. Jay Pharma Recent Development
Table 74. Research Programs/Design for This Report
Table 75. Key Data Information from Secondary Sources
Table 76. Key Data Information from Primary Sources
Table 1. Global Cannabinoid-based Products for Cancer Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Smoking Products
Table 3. Key Players of Food Products
Table 4. Key Players of Oil
Table 5. Key Players of Coat Product
Table 6. Key Players of Other
Table 7. Global Cannabinoid-based Products for Cancer Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 8. Global Cannabinoid-based Products for Cancer Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 9. Global Cannabinoid-based Products for Cancer Market Size by Region (2018-2023) & (US$ Million)
Table 10. Global Cannabinoid-based Products for Cancer Market Share by Region (2018-2023)
Table 11. Global Cannabinoid-based Products for Cancer Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 12. Global Cannabinoid-based Products for Cancer Market Share by Region (2024-2029)
Table 13. Cannabinoid-based Products for Cancer Market Trends
Table 14. Cannabinoid-based Products for Cancer Market Drivers
Table 15. Cannabinoid-based Products for Cancer Market Challenges
Table 16. Cannabinoid-based Products for Cancer Market Restraints
Table 17. Global Cannabinoid-based Products for Cancer Revenue by Players (2018-2023) & (US$ Million)
Table 18. Global Cannabinoid-based Products for Cancer Market Share by Players (2018-2023)
Table 19. Global Top Cannabinoid-based Products for Cancer Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cannabinoid-based Products for Cancer as of 2022)
Table 20. Ranking of Global Top Cannabinoid-based Products for Cancer Companies by Revenue (US$ Million) in 2022
Table 21. Global 5 Largest Players Market Share by Cannabinoid-based Products for Cancer Revenue (CR5 and HHI) & (2018-2023)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Cannabinoid-based Products for Cancer Product Solution and Service
Table 24. Date of Enter into Cannabinoid-based Products for Cancer Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Cannabinoid-based Products for Cancer Market Size by Type (2018-2023) & (US$ Million)
Table 27. Global Cannabinoid-based Products for Cancer Revenue Market Share by Type (2018-2023)
Table 28. Global Cannabinoid-based Products for Cancer Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 29. Global Cannabinoid-based Products for Cancer Revenue Market Share by Type (2024-2029)
Table 30. Global Cannabinoid-based Products for Cancer Market Size by Application (2018-2023) & (US$ Million)
Table 31. Global Cannabinoid-based Products for Cancer Revenue Market Share by Application (2018-2023)
Table 32. Global Cannabinoid-based Products for Cancer Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 33. Global Cannabinoid-based Products for Cancer Revenue Market Share by Application (2024-2029)
Table 34. North America Cannabinoid-based Products for Cancer Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. North America Cannabinoid-based Products for Cancer Market Size by Country (2018-2023) & (US$ Million)
Table 36. North America Cannabinoid-based Products for Cancer Market Size by Country (2024-2029) & (US$ Million)
Table 37. Europe Cannabinoid-based Products for Cancer Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 38. Europe Cannabinoid-based Products for Cancer Market Size by Country (2018-2023) & (US$ Million)
Table 39. Europe Cannabinoid-based Products for Cancer Market Size by Country (2024-2029) & (US$ Million)
Table 40. Asia-Pacific Cannabinoid-based Products for Cancer Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 41. Asia-Pacific Cannabinoid-based Products for Cancer Market Size by Region (2018-2023) & (US$ Million)
Table 42. Asia-Pacific Cannabinoid-based Products for Cancer Market Size by Region (2024-2029) & (US$ Million)
Table 43. Latin America Cannabinoid-based Products for Cancer Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Latin America Cannabinoid-based Products for Cancer Market Size by Country (2018-2023) & (US$ Million)
Table 45. Latin America Cannabinoid-based Products for Cancer Market Size by Country (2024-2029) & (US$ Million)
Table 46. Middle East & Africa Cannabinoid-based Products for Cancer Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 47. Middle East & Africa Cannabinoid-based Products for Cancer Market Size by Country (2018-2023) & (US$ Million)
Table 48. Middle East & Africa Cannabinoid-based Products for Cancer Market Size by Country (2024-2029) & (US$ Million)
Table 49. Bausch Health Company Detail
Table 50. Bausch Health Business Overview
Table 51. Bausch Health Cannabinoid-based Products for Cancer Product
Table 52. Bausch Health Revenue in Cannabinoid-based Products for Cancer Business (2018-2023) & (US$ Million)
Table 53. Bausch Health Recent Development
Table 54. GW Pharmaceuticals Company Detail
Table 55. GW Pharmaceuticals Business Overview
Table 56. GW Pharmaceuticals Cannabinoid-based Products for Cancer Product
Table 57. GW Pharmaceuticals Revenue in Cannabinoid-based Products for Cancer Business (2018-2023) & (US$ Million)
Table 58. GW Pharmaceuticals Recent Development
Table 59. Cannabics Inc. Company Detail
Table 60. Cannabics Inc. Business Overview
Table 61. Cannabics Inc. Cannabinoid-based Products for Cancer Product
Table 62. Cannabics Inc. Revenue in Cannabinoid-based Products for Cancer Business (2018-2023) & (US$ Million)
Table 63. Cannabics Inc. Recent Development
Table 64. Tikun Olam Company Detail
Table 65. Tikun Olam Business Overview
Table 66. Tikun Olam Cannabinoid-based Products for Cancer Product
Table 67. Tikun Olam Revenue in Cannabinoid-based Products for Cancer Business (2018-2023) & (US$ Million)
Table 68. Tikun Olam Recent Development
Table 69. Jay Pharma Company Detail
Table 70. Jay Pharma Business Overview
Table 71. Jay Pharma Cannabinoid-based Products for Cancer Product
Table 72. Jay Pharma Revenue in Cannabinoid-based Products for Cancer Business (2018-2023) & (US$ Million)
Table 73. Jay Pharma Recent Development
Table 74. Research Programs/Design for This Report
Table 75. Key Data Information from Secondary Sources
Table 76. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Global Cannabinoid-based Products for Cancer Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Cannabinoid-based Products for Cancer Market Share by Type: 2022 VS 2029
Figure 3. Smoking Products Features
Figure 4. Food Products Features
Figure 5. Oil Features
Figure 6. Coat Product Features
Figure 7. Other Features
Figure 8. Global Cannabinoid-based Products for Cancer Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 9. Global Cannabinoid-based Products for Cancer Market Share by Application: 2022 VS 2029
Figure 10. Clinics Case Studies
Figure 11. Hospitals Case Studies
Figure 12. Others Case Studies
Figure 13. Cannabinoid-based Products for Cancer Report Years Considered
Figure 14. Global Cannabinoid-based Products for Cancer Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 15. Global Cannabinoid-based Products for Cancer Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 16. Global Cannabinoid-based Products for Cancer Market Share by Region: 2022 VS 2029
Figure 17. Global Cannabinoid-based Products for Cancer Market Share by Players in 2022
Figure 18. Global Top Cannabinoid-based Products for Cancer Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cannabinoid-based Products for Cancer as of 2022)
Figure 19. The Top 10 and 5 Players Market Share by Cannabinoid-based Products for Cancer Revenue in 2022
Figure 20. North America Cannabinoid-based Products for Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. North America Cannabinoid-based Products for Cancer Market Share by Country (2018-2029)
Figure 22. United States Cannabinoid-based Products for Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Canada Cannabinoid-based Products for Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Europe Cannabinoid-based Products for Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Europe Cannabinoid-based Products for Cancer Market Share by Country (2018-2029)
Figure 26. Germany Cannabinoid-based Products for Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. France Cannabinoid-based Products for Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. U.K. Cannabinoid-based Products for Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Italy Cannabinoid-based Products for Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Russia Cannabinoid-based Products for Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Nordic Countries Cannabinoid-based Products for Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Asia-Pacific Cannabinoid-based Products for Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Asia-Pacific Cannabinoid-based Products for Cancer Market Share by Region (2018-2029)
Figure 34. China Cannabinoid-based Products for Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Japan Cannabinoid-based Products for Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. South Korea Cannabinoid-based Products for Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Southeast Asia Cannabinoid-based Products for Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. India Cannabinoid-based Products for Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Australia Cannabinoid-based Products for Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Latin America Cannabinoid-based Products for Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Latin America Cannabinoid-based Products for Cancer Market Share by Country (2018-2029)
Figure 42. Mexico Cannabinoid-based Products for Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Brazil Cannabinoid-based Products for Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Middle East & Africa Cannabinoid-based Products for Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Middle East & Africa Cannabinoid-based Products for Cancer Market Share by Country (2018-2029)
Figure 46. Turkey Cannabinoid-based Products for Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Saudi Arabia Cannabinoid-based Products for Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Bausch Health Revenue Growth Rate in Cannabinoid-based Products for Cancer Business (2018-2023)
Figure 49. GW Pharmaceuticals Revenue Growth Rate in Cannabinoid-based Products for Cancer Business (2018-2023)
Figure 50. Cannabics Inc. Revenue Growth Rate in Cannabinoid-based Products for Cancer Business (2018-2023)
Figure 51. Tikun Olam Revenue Growth Rate in Cannabinoid-based Products for Cancer Business (2018-2023)
Figure 52. Jay Pharma Revenue Growth Rate in Cannabinoid-based Products for Cancer Business (2018-2023)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed
Figure 1. Global Cannabinoid-based Products for Cancer Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Cannabinoid-based Products for Cancer Market Share by Type: 2022 VS 2029
Figure 3. Smoking Products Features
Figure 4. Food Products Features
Figure 5. Oil Features
Figure 6. Coat Product Features
Figure 7. Other Features
Figure 8. Global Cannabinoid-based Products for Cancer Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 9. Global Cannabinoid-based Products for Cancer Market Share by Application: 2022 VS 2029
Figure 10. Clinics Case Studies
Figure 11. Hospitals Case Studies
Figure 12. Others Case Studies
Figure 13. Cannabinoid-based Products for Cancer Report Years Considered
Figure 14. Global Cannabinoid-based Products for Cancer Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 15. Global Cannabinoid-based Products for Cancer Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 16. Global Cannabinoid-based Products for Cancer Market Share by Region: 2022 VS 2029
Figure 17. Global Cannabinoid-based Products for Cancer Market Share by Players in 2022
Figure 18. Global Top Cannabinoid-based Products for Cancer Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cannabinoid-based Products for Cancer as of 2022)
Figure 19. The Top 10 and 5 Players Market Share by Cannabinoid-based Products for Cancer Revenue in 2022
Figure 20. North America Cannabinoid-based Products for Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. North America Cannabinoid-based Products for Cancer Market Share by Country (2018-2029)
Figure 22. United States Cannabinoid-based Products for Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Canada Cannabinoid-based Products for Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Europe Cannabinoid-based Products for Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Europe Cannabinoid-based Products for Cancer Market Share by Country (2018-2029)
Figure 26. Germany Cannabinoid-based Products for Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. France Cannabinoid-based Products for Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. U.K. Cannabinoid-based Products for Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Italy Cannabinoid-based Products for Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Russia Cannabinoid-based Products for Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Nordic Countries Cannabinoid-based Products for Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Asia-Pacific Cannabinoid-based Products for Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Asia-Pacific Cannabinoid-based Products for Cancer Market Share by Region (2018-2029)
Figure 34. China Cannabinoid-based Products for Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Japan Cannabinoid-based Products for Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. South Korea Cannabinoid-based Products for Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Southeast Asia Cannabinoid-based Products for Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. India Cannabinoid-based Products for Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Australia Cannabinoid-based Products for Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Latin America Cannabinoid-based Products for Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Latin America Cannabinoid-based Products for Cancer Market Share by Country (2018-2029)
Figure 42. Mexico Cannabinoid-based Products for Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Brazil Cannabinoid-based Products for Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Middle East & Africa Cannabinoid-based Products for Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Middle East & Africa Cannabinoid-based Products for Cancer Market Share by Country (2018-2029)
Figure 46. Turkey Cannabinoid-based Products for Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Saudi Arabia Cannabinoid-based Products for Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Bausch Health Revenue Growth Rate in Cannabinoid-based Products for Cancer Business (2018-2023)
Figure 49. GW Pharmaceuticals Revenue Growth Rate in Cannabinoid-based Products for Cancer Business (2018-2023)
Figure 50. Cannabics Inc. Revenue Growth Rate in Cannabinoid-based Products for Cancer Business (2018-2023)
Figure 51. Tikun Olam Revenue Growth Rate in Cannabinoid-based Products for Cancer Business (2018-2023)
Figure 52. Jay Pharma Revenue Growth Rate in Cannabinoid-based Products for Cancer Business (2018-2023)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed
